{"id":39080,"date":"2026-09-25T05:35:15","date_gmt":"2026-09-25T05:35:15","guid":{"rendered":"https:\/\/expresorgv.online\/home\/?p=39080"},"modified":"2026-09-25T05:35:16","modified_gmt":"2026-09-25T05:35:16","slug":"cofepris-autoriza-primera-inyeccion-semestral-contra-vih","status":"publish","type":"post","link":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/","title":{"rendered":"Cofepris autoriza primera inyecci\u00f3n semestral contra VIH"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Las autoridades sanitarias mexicanas autorizaron el uso de lenacapavir para la profilaxis preexposici\u00f3n (PrEP) contra el virus de inmunodeficiencia humana (VIH), un medicamento de acci\u00f3n prolongada que se administra mediante una inyecci\u00f3n subcut\u00e1nea dos veces al a\u00f1o.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) inform\u00f3 este jueves de que otorg\u00f3 el registro sanitario al medicamento tras analizar la evidencia disponible sobre su calidad, seguridad y eficacia.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Con la autorizaci\u00f3n, M\u00e9xico se suma a pa\u00edses como Brasil y Estados Unidos, adem\u00e1s de los miembros de la Uni\u00f3n Europea, que cuentan con esta alternativa para prevenir la infecci\u00f3n por VIH, seg\u00fan el organismo sanitario.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El lenacapavir representa una nueva opci\u00f3n frente a esquemas de PrEP que requieren una toma diaria o aplicaciones m\u00e1s frecuentes, una caracter\u00edstica que podr\u00eda facilitar la adherencia a las estrategias preventivas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La Organizaci\u00f3n Mundial de la Salud (OMS) recomend\u00f3 en julio de 2025 ofrecer el lenacapavir inyectable dos veces al a\u00f1o como una opci\u00f3n adicional de PrEP y destac\u00f3 su potencial para personas que tienen dificultades para mantener tratamientos diarios o enfrentan barreras como el estigma o el acceso frecuente a los servicios sanitarios.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Ensayos con alta eficacia<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">La autorizaci\u00f3n mexicana llega despu\u00e9s de los ensayos cl\u00ednicos de fase 3 PURPOSE 1 y PURPOSE 2, que evaluaron la seguridad y eficacia del medicamento en distintas poblaciones.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En PURPOSE 1 no se registraron nuevas infecciones por VIH entre las 2.134 participantes que recibieron lenacapavir, mientras que PURPOSE 2 registr\u00f3 dos infecciones entre quienes recibieron el f\u00e1rmaco, seg\u00fan la documentaci\u00f3n de la Administraci\u00f3n de Alimentos y Medicamentos de Estados Unidos (FDA).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Este \u00faltimo ensayo incluy\u00f3 a hombres cisg\u00e9nero, mujeres y hombres transg\u00e9nero y personas no binarias que ten\u00edan relaciones sexuales con personas de sexo masculino.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/i0.wp.com\/editorial.aristeguinoticias.com\/wp-content\/uploads\/2023\/03\/CIENCIA-mujercuradadeVIH-16032023-3.png?ssl=1\"><img decoding=\"async\" src=\"https:\/\/i0.wp.com\/editorial.aristeguinoticias.com\/wp-content\/uploads\/2023\/03\/CIENCIA-mujercuradadeVIH-16032023-3-700x438.png?resize=640%2C400&#038;ssl=1\" alt=\"\" data-recalc-dims=\"1\" \/><\/a><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">M\u00e9xico particip\u00f3 desde 2023 en el desarrollo cl\u00ednico del medicamento, cuando Cofepris autoriz\u00f3 el protocolo de investigaci\u00f3n GS-US-528-9023, correspondiente precisamente al estudio PURPOSE 2, para evaluar el uso preventivo del lenacapavir de acci\u00f3n prolongada administrado dos veces al a\u00f1o.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La FDA estadounidense autoriz\u00f3 en junio de 2025 el lenacapavir inyectable para la prevenci\u00f3n del VIH, una decisi\u00f3n que la OMS calific\u00f3 entonces como un avance para ampliar las opciones de profilaxis disponibles.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Un mes despu\u00e9s, la OMS incorpor\u00f3 formalmente el f\u00e1rmaco a sus recomendaciones y lo describi\u00f3 como la primera opci\u00f3n de PrEP inyectable de administraci\u00f3n semestral.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La PrEP est\u00e1 dirigida a personas que no tienen VIH pero presentan riesgo de adquirirlo y utiliza medicamentos antirretrovirales para reducir la probabilidad de infecci\u00f3n.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">M\u00e9xico mantiene un sistema de vigilancia epidemiol\u00f3gica del VIH, cuyos datos son recopilados por la Secretar\u00eda de Salud y el Centro Nacional para la Prevenci\u00f3n y Control del VIH y el Sida (Censida), que publica peri\u00f3dicamente informaci\u00f3n sobre nuevos diagn\u00f3sticos y atenci\u00f3n de las personas que viven con el virus.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Las autoridades sanitarias mexicanas autorizaron el uso de lenacapavir para la profilaxis preexposici\u00f3n (PrEP) contra el virus de inmunodeficiencia humana (VIH), un medicamento de acci\u00f3n prolongada que se administra mediante una inyecci\u00f3n subcut\u00e1nea dos veces al a\u00f1o. La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) inform\u00f3 este jueves de que otorg\u00f3 el registro [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":39066,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-39080","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nacional"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cofepris autoriza primera inyecci\u00f3n semestral contra VIH -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cofepris autoriza primera inyecci\u00f3n semestral contra VIH\" \/>\n<meta property=\"og:description\" content=\"Las autoridades sanitarias mexicanas autorizaron el uso de lenacapavir para la profilaxis preexposici\u00f3n (PrEP) contra el virus de inmunodeficiencia humana (VIH), un medicamento de acci\u00f3n prolongada que se administra mediante una inyecci\u00f3n subcut\u00e1nea dos veces al a\u00f1o. La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) inform\u00f3 este jueves de que otorg\u00f3 el registro [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-25T05:35:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-25T05:35:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png\" \/>\n\t<meta property=\"og:image:width\" content=\"540\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"expreso\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"expreso\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/\"},\"author\":{\"name\":\"expreso\",\"@id\":\"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2\"},\"headline\":\"Cofepris autoriza primera inyecci\u00f3n semestral contra VIH\",\"datePublished\":\"2026-09-25T05:35:15+00:00\",\"dateModified\":\"2026-09-25T05:35:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/\"},\"wordCount\":510,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png?fit=540%2C300&ssl=1\",\"articleSection\":[\"NACIONAL\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/\",\"url\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/\",\"name\":\"Cofepris autoriza primera inyecci\u00f3n semestral contra VIH -\",\"isPartOf\":{\"@id\":\"https:\/\/expresorgv.online\/home\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png?fit=540%2C300&ssl=1\",\"datePublished\":\"2026-09-25T05:35:15+00:00\",\"dateModified\":\"2026-09-25T05:35:16+00:00\",\"author\":{\"@id\":\"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2\"},\"breadcrumb\":{\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png?fit=540%2C300&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png?fit=540%2C300&ssl=1\",\"width\":540,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/expresorgv.online\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cofepris autoriza primera inyecci\u00f3n semestral contra VIH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/expresorgv.online\/home\/#website\",\"url\":\"https:\/\/expresorgv.online\/home\/\",\"name\":\"\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/expresorgv.online\/home\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2\",\"name\":\"expreso\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g\",\"caption\":\"expreso\"},\"url\":\"https:\/\/expresorgv.online\/home\/blog\/author\/expreso\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cofepris autoriza primera inyecci\u00f3n semestral contra VIH -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/","og_locale":"es_ES","og_type":"article","og_title":"Cofepris autoriza primera inyecci\u00f3n semestral contra VIH","og_description":"Las autoridades sanitarias mexicanas autorizaron el uso de lenacapavir para la profilaxis preexposici\u00f3n (PrEP) contra el virus de inmunodeficiencia humana (VIH), un medicamento de acci\u00f3n prolongada que se administra mediante una inyecci\u00f3n subcut\u00e1nea dos veces al a\u00f1o. La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) inform\u00f3 este jueves de que otorg\u00f3 el registro [&hellip;]","og_url":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/","article_published_time":"2026-09-25T05:35:15+00:00","article_modified_time":"2026-09-25T05:35:16+00:00","og_image":[{"width":540,"height":300,"url":"https:\/\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png","type":"image\/png"}],"author":"expreso","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"expreso","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#article","isPartOf":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/"},"author":{"name":"expreso","@id":"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2"},"headline":"Cofepris autoriza primera inyecci\u00f3n semestral contra VIH","datePublished":"2026-09-25T05:35:15+00:00","dateModified":"2026-09-25T05:35:16+00:00","mainEntityOfPage":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/"},"wordCount":510,"commentCount":0,"image":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png?fit=540%2C300&ssl=1","articleSection":["NACIONAL"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/","url":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/","name":"Cofepris autoriza primera inyecci\u00f3n semestral contra VIH -","isPartOf":{"@id":"https:\/\/expresorgv.online\/home\/#website"},"primaryImageOfPage":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#primaryimage"},"image":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png?fit=540%2C300&ssl=1","datePublished":"2026-09-25T05:35:15+00:00","dateModified":"2026-09-25T05:35:16+00:00","author":{"@id":"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2"},"breadcrumb":{"@id":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#primaryimage","url":"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png?fit=540%2C300&ssl=1","contentUrl":"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png?fit=540%2C300&ssl=1","width":540,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/expresorgv.online\/home\/blog\/2026\/09\/25\/cofepris-autoriza-primera-inyeccion-semestral-contra-vih\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/expresorgv.online\/home\/"},{"@type":"ListItem","position":2,"name":"Cofepris autoriza primera inyecci\u00f3n semestral contra VIH"}]},{"@type":"WebSite","@id":"https:\/\/expresorgv.online\/home\/#website","url":"https:\/\/expresorgv.online\/home\/","name":"","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/expresorgv.online\/home\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/expresorgv.online\/home\/#\/schema\/person\/ae1ed1a575540204b5f59dca7f91f6a2","name":"expreso","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/88cd9f065dcd1b722cd984aac4181386a800c0bca699eaf07e42dd8f820bddee?s=96&d=mm&r=g","caption":"expreso"},"url":"https:\/\/expresorgv.online\/home\/blog\/author\/expreso\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/expresorgv.online\/home\/wp-content\/uploads\/2026\/09\/25092026InyeccionVIH.png?fit=540%2C300&ssl=1","_links":{"self":[{"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/posts\/39080","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/comments?post=39080"}],"version-history":[{"count":1,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/posts\/39080\/revisions"}],"predecessor-version":[{"id":39081,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/posts\/39080\/revisions\/39081"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/media\/39066"}],"wp:attachment":[{"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/media?parent=39080"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/categories?post=39080"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/expresorgv.online\/home\/wp-json\/wp\/v2\/tags?post=39080"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}